medigraphic.com
SPANISH

Archivos de Cardiología de México

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2001, Number S1

<< Back Next >>

Arch Cardiol Mex 2001; 71 (S1)

Treatment of the ventricular tachycardia

Iturralde TP
Full text How to cite this article

Language: Spanish
References: 10
Page: 81-84
PDF size: 35.70 Kb.


Key words:

Ventricular, tachycardia, Antiarrhythmic, Radiofrequency ablation.

ABSTRACT

Evaluation and management of postinfarct ventricular tachycardia has changed dramatically in the past two decades. The introduction of the implantable cardioverter defibrillator has played a major role in this change, alternating both, the purpose of the patients evaluation and treatment options. Episodes of sustained ventricular tachycardia can occur in a variety of clinical settings; the most common of which is the patient who has suffered a myocardial infarction. In this paper, I explore the causes and effects of some of these changes and review current strategies, specially the radiofrequency catheter ablation, for the management of the patient with postinfarct ventricular tachycardia.


REFERENCES

  1. JOSEPHSON ME, WELLENS HJJ: Tachycardias, mechanism, diagnosis, management. Phyladelphia: Lea & Febiger 1984: 229-413.

  2. TCHOU P, JAZAYERI M, DENKER S, DONGAS J, AKHTAR M: Transcatheter electrical ablation of right bundle branch: a method of treating macroreentrant ventricular tachycardia attributed to bundle branch reentry. Circulation 1988; 78: 246-257.

  3. KLEIN LS, SHIH HT, HACKETT FK, ZIPES DP, MILES WM: Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease. Circulation 1992; 85: 1666-1674.

  4. CALKINS H, KALBFLEISCH S, EL-ATASSI R, LANGBERG J, MORADY F: Relation between efficacy of radiofrequency catheter ablation and site of origin of idiopathic ventricular tachycardia. Am J Cardiol 1993; 71: 827-833.

  5. MORADY F, KADISH A, ROSENHECK S, CALKINS H, KOW WH DE BUITLEIR M, ET AL: Concealed entrainment as a guide for catheter ablation of ventricular tachycardia in patients with a prior myocardial infarction. J Am Coll Cardiol 1991; 17: 678-689.

  6. MILLER JM, COPPESS MA, ALTEMOSE GT, GERVACIO GD, SCOTT LR: Management of postinfarct ventricular tachycardias. Cardiol Clin 2000; 18-2: 293-307.

  7. GONSKA BD, CAO K, ACHAUMANN A, DORSZEWSKI A, MUHLEN F, KREAZAE H: Catheter ablation of ventricular tachycardia in 136 patients with coronary artery disease and long term follow up. J Am Coll Cardiol 1994; 24(6): 1506-1514.

  8. MIROWSKI M, REIS PR, MOWER MM: Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. New Engl J Med 1980; 303: 322-324.

  9. WINKLE RA, MEAD RH, RUDER MA, GAUDINI VA, SMITH MA, BUSH WS, ET AL: Long term outcome with the automatic implantable cardioverter-desfibrillator. J Am Coll Cardiol 1989; 13(6): 1353-1361.

  10. LEHMANN MH, SAKSENA S and the Naspe Policy Conference Committee. Implantable cardioverter defibrillators in cardiovascular practice. PACE 1991; 14: 969-979.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Arch Cardiol Mex. 2001;71